1. Home
  2. YSWY vs FDMT Comparison

YSWY vs FDMT Comparison

Compare YSWY & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yesway Inc. Class A Common Stock

YSWY

Yesway Inc. Class A Common Stock

N/A

Current Price

$24.74

Market Cap

764.2M

ML Signal

N/A

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

N/A

Current Price

$11.88

Market Cap

695.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YSWY
FDMT
Founded
2015
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
764.2M
695.3M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
YSWY
FDMT
Price
$24.74
$11.88
Analyst Decision
Buy
Strong Buy
Analyst Count
9
12
Target Price
★ $29.63
$28.09
AVG Volume (30 Days)
248.9K
★ 971.2K
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.79
EPS
N/A
★ N/A
Revenue
N/A
★ $85,209,000.00
Revenue This Year
$23.20
N/A
Revenue Next Year
N/A
$55.65
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 230194.60
52 Week Low
$18.92
$6.96
52 Week High
$26.34
$16.93

Technical Indicators

Market Signals
Indicator
YSWY
FDMT
Relative Strength Index (RSI) 65.76 44.00
Support Level $18.92 $8.68
Resistance Level $26.34 $11.96
Average True Range (ATR) 0.93 0.94
MACD 0.24 0.04
Stochastic Oscillator 87.61 44.43

Price Performance

Historical Comparison
YSWY
FDMT

About YSWY Yesway Inc. Class A Common Stock

Yesway Inc is a U.S.-based convenience store operator that manages retail locations under the Yesway and Allsup's brands. Its stores offer foodservice products, grocery items, and private-label products. The company operates in rural and suburban markets across the Southwest and Midwest regions of the United States. It derives its revenue in the United States by operating convenience stores that offer merchandise, fuel, and other products and services designed to appeal to the convenience needs of the customers.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Share on Social Networks: